Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlamydia trachomatis | 2 | 2019 | 6 | 1.200 |
Why?
|
| Isothiocyanates | 1 | 2019 | 6 | 0.690 |
Why?
|
| Complement C3 | 1 | 2019 | 7 | 0.690 |
Why?
|
| Chlamydia Infections | 1 | 2019 | 5 | 0.690 |
Why?
|
| Complement Activation | 1 | 2019 | 10 | 0.680 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 67 | 0.650 |
Why?
|
| Bacterial Adhesion | 1 | 2014 | 7 | 0.520 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 42 | 0.510 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 30 | 0.510 |
Why?
|
| Head and Neck Neoplasms | 4 | 2017 | 117 | 0.480 |
Why?
|
| Oxidation-Reduction | 5 | 2019 | 250 | 0.400 |
Why?
|
| Cysteine | 4 | 2017 | 131 | 0.400 |
Why?
|
| Radiation Tolerance | 3 | 2015 | 22 | 0.380 |
Why?
|
| Hela Cells | 2 | 2019 | 78 | 0.300 |
Why?
|
| NIH 3T3 Cells | 4 | 2014 | 43 | 0.210 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 99 | 0.200 |
Why?
|
| Sulfenic Acids | 2 | 2012 | 52 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 69 | 0.200 |
Why?
|
| Proteins | 2 | 2012 | 140 | 0.190 |
Why?
|
| Mice | 6 | 2017 | 2368 | 0.180 |
Why?
|
| Glucose | 2 | 2017 | 163 | 0.170 |
Why?
|
| Phosphorylation | 3 | 2014 | 225 | 0.170 |
Why?
|
| Peroxiredoxins | 2 | 2010 | 106 | 0.160 |
Why?
|
| Sulfones | 1 | 2017 | 14 | 0.150 |
Why?
|
| Phenols | 1 | 2017 | 16 | 0.150 |
Why?
|
| Sirtuins | 1 | 2017 | 19 | 0.150 |
Why?
|
| Drug Discovery | 1 | 2017 | 30 | 0.150 |
Why?
|
| Tetrazoles | 1 | 2017 | 71 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2019 | 223 | 0.150 |
Why?
|
| Homeostasis | 1 | 2017 | 127 | 0.150 |
Why?
|
| Monocytes | 1 | 2017 | 119 | 0.140 |
Why?
|
| Humans | 11 | 2019 | 29093 | 0.130 |
Why?
|
| Animals | 7 | 2017 | 7297 | 0.130 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2015 | 7 | 0.130 |
Why?
|
| Cyclin D2 | 1 | 2015 | 7 | 0.130 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2011 | 13 | 0.130 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 34 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2011 | 56 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 72 | 0.120 |
Why?
|
| Quinazolines | 1 | 2014 | 31 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2015 | 139 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2015 | 130 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 142 | 0.110 |
Why?
|
| Cyclopentanes | 1 | 2011 | 17 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2011 | 69 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2011 | 103 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 158 | 0.090 |
Why?
|
| Phosphines | 1 | 2010 | 3 | 0.090 |
Why?
|
| S-Nitrosoglutathione | 1 | 2010 | 4 | 0.090 |
Why?
|
| S-Nitrosothiols | 1 | 2010 | 5 | 0.090 |
Why?
|
| Salmonella typhimurium | 1 | 2010 | 33 | 0.090 |
Why?
|
| Sulfinic Acids | 1 | 2008 | 11 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 2008 | 20 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 680 | 0.060 |
Why?
|
| Staining and Labeling | 2 | 2012 | 56 | 0.050 |
Why?
|
| Models, Biological | 2 | 2017 | 373 | 0.050 |
Why?
|
| Cell Line | 2 | 2011 | 449 | 0.050 |
Why?
|
| Oxidants | 1 | 2019 | 15 | 0.040 |
Why?
|
| Antioxidants | 1 | 2019 | 114 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 1 | 2017 | 5 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2011 | 666 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 67 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2017 | 53 | 0.040 |
Why?
|
| Computational Biology | 1 | 2017 | 86 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2017 | 97 | 0.040 |
Why?
|
| Mutation | 2 | 2010 | 466 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2017 | 799 | 0.030 |
Why?
|
| Glycolysis | 1 | 2015 | 19 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 44 | 0.030 |
Why?
|
| Azacitidine | 1 | 2015 | 28 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2014 | 22 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 212 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 158 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 249 | 0.030 |
Why?
|
| Mitochondria | 1 | 2015 | 174 | 0.030 |
Why?
|
| Esters | 1 | 2012 | 9 | 0.030 |
Why?
|
| Ketones | 1 | 2012 | 7 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 629 | 0.030 |
Why?
|
| G1 Phase | 1 | 2011 | 8 | 0.030 |
Why?
|
| S Phase | 1 | 2011 | 11 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2012 | 178 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 5 | 0.030 |
Why?
|
| DNA Primers | 1 | 2011 | 87 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 60 | 0.030 |
Why?
|
| Cell Survival | 1 | 2012 | 272 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2011 | 33 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 240 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 280 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 350 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 161 | 0.020 |
Why?
|
| Nitrosation | 1 | 2010 | 4 | 0.020 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2008 | 5 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2008 | 30 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2008 | 17 | 0.020 |
Why?
|
| Glutathione | 1 | 2008 | 37 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 205 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 2001 | 0.010 |
Why?
|